Co-Diagnostics, Inc. (CODX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.87-0.06 (-0.62%)
At close: 4:00PM EDT
8.86 -0.01 (-0.11%)
After hours: 6:27PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 9.40 |
| Open | 9.44 |
| Bid | 8.70 x 1300 |
| Ask | 8.93 x 1200 |
| Day's Range | 8.78 - 9.60 |
| 52 Week Range | 7.86 - 30.99 |
| Volume | 799,646 |
| Avg. Volume | 1,634,125 |
| Market Cap | 254.265M |
| Beta (5Y Monthly) | -1.93 |
| PE Ratio (TTM) | 5.84 |
| EPS (TTM) | 1.52 |
| Earnings Date | May 12, 2021 - May 17, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.00 |
- PR Newswire
Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance
The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo! Finance to comment on the Company's recently-released FY2020 earnings report, and to discuss its going-forward strategy as the world struggles to achieve normalization.
- Yahoo Finance Video
'We believe robust testing will be required in order to normalize' post-pandemic: Co-Diagnostics CEO
Co-Diagnostics CEO Dwight Egan joined the Yahoo Finance Live panel to discuss the company's Q4 earnings results, along with the latest at-home COVID-19 testing outlook.
- Simply Wall St.
Some Co-Diagnostics, Inc. (NASDAQ:CODX) Analysts Just Made A Major Cut To Next Year's Estimates
The analysts covering Co-Diagnostics, Inc. ( NASDAQ:CODX ) delivered a dose of negativity to shareholders today, by...
© 2021 Verizon Media. All rights reserved.
